Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUs Solar Fund Regulatory News (USFP)

Share Price Information for Us Solar Fund (USFP)

Share Price is delayed by 15 minutes
Get Live Data
26.90    0.10 (0.37%)
Bid:
25.20
Ask:
28.60
Spread: 3.40 (13.492%)
Market Cap: £83.12m
USFP Live PriceLast checked at - London Stock Exchange

Intraday Us Solar Fund Share Chart

Form 8.3 - US Solar Fund Plc

10 Mar 2023 11:51

RNS Number : 6118S
Sarasin & Partners LLP
10 March 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Sarasin & Partners LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

US Solar Fund Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

9 March 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

USD 0.01 ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

28,781,609

8.66%

 

 

(2) Cash-settled derivatives:

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

TOTAL:

28,781,609

8.66%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

USD 0.01 ordinary

Sale

 

19,917

(USD) 0.8000

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

10 March 2023

Contact name:

Polly Warburton

Telephone number*:

020 7038 7198

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETBBGDXGUBDGXG
Date   Source Headline
28th May 20263:45 pmRNSResult of AGM
18th May 20269:30 amRNSPotential Portfolio Sale - Award Of Exclusivity
19th Mar 20267:00 amRNSDividend Declaration
19th Mar 20267:00 amRNSFull Year Results to 31 Dec 2025 & Notice of AGM
13th Mar 20267:00 amRNSNotice of Results
13th Mar 20267:00 amRNSNotice of Results
16th Dec 20257:00 amRNSThird Quarter Portfolio Performance
26th Nov 20257:00 amRNSDividend Declaration
26th Nov 20257:00 amRNSThird Quarter Update
3rd Oct 202511:25 amRNSHolding(s) in Company
2nd Oct 20252:35 pmRNSHolding(s) in Company
2nd Oct 20251:21 pmRNSHolding(s) in Company
1st Oct 20251:36 pmRNSHolding(s) in Company
29th Sep 20255:07 pmRNSHolding(s) in Company
26th Sep 20255:10 pmRNSHolding(s) in Company
16th Sep 20257:05 amRNSDividend Declaration
16th Sep 20257:00 amRNSInterim Results to 30 June 2025
5th Sep 202512:00 pmRNSNotice of Results
26th Aug 20254:55 pmRNSHolding(s) in Company
24th Jul 202511:15 amRNSHolding(s) in Company
17th Jul 20254:40 pmRNSHolding(s) in Company
16th Jun 20257:00 amRNSFirst Quarter Update
29th May 20254:21 pmRNSHolding(s) in Company
21st May 20257:00 amRNSDividend Declaration
20th May 20254:49 pmRNSResult of AGM
1st May 20255:15 pmRNSHolding(s) in Company
1st May 20254:47 pmRNSHolding(s) in Company
30th Apr 20255:12 pmRNSHolding(s) in Company
30th Apr 20253:56 pmRNSHolding(s) in Company
25th Apr 20255:11 pmRNSHolding(s) in Company
23rd Apr 202512:46 pmRNSHolding(s) in Company
17th Apr 202512:24 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSPortfolio Debt Financing Completion & Dividend
10th Apr 20257:05 amRNSDividend Declaration
10th Apr 20257:00 amRNSFull Year Results and Notice of AGM
28th Mar 20257:00 amRNSNotice of Results and Investor Presentation
14th Jan 20259:11 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSUpdate on Refinancing
20th Dec 202411:00 amRNSHolding(s) in Company
25th Nov 20247:00 amRNSTHIRD QUARTER UPDATE
21st Nov 20247:00 amRNSDividend Declaration
12th Nov 20246:19 pmRNSHolding(s) in Company
8th Nov 20244:30 pmRNSHolding(s) in Company
25th Oct 202410:02 amRNSHolding(s) in Company
24th Oct 20244:27 pmRNSHolding(s) in Company
30th Sep 202411:59 amRNSReplacement Interim Results to 30 June 2024
30th Sep 20247:10 amRNSDividend Declaration
30th Sep 20247:05 amRNSInterim Results to 30 June 2024
30th Sep 20247:00 amRNSUpdate on Oregon RECs & Board Appointment
26th Sep 202412:13 pmRNSNotice of Results and Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.